An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study-Reference-Cited by-同舟云学术

An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study

Published:2023-06 Issue:3 Volume:6 Page:295-302
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Eldred-Evans David,Tam Henry,Sokhi Heminder,Padhani Anwar R.,Connor Martin,Price Derek,Gammon Martin,Klimowska-Nassar Natalia,Burak Paula,Day Emily,Winkler Mathias,Fiorentino Francesca,Ahmed Hashim U.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference20 articles.

1. Screening for prostate cancer at low PSA range: The impact of digital rectal examination on tumor incidence and tumor characteristics;Gosselaar;Prostate,2007

2. Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study;Eldred-Evans;JAMA Oncol,2021

3. A pilot study to evaluate the role of magnetic resonance imaging for prostate cancer screening in the general population;Nam;J Urol,2016

4. Role of magnetic resonance imaging in prostate cancer screening: a pilot study within the Göteborg randomised screening trial;Grenabo Bergdahl;Eur Urol,2016

5. Rethinking prostate cancer screening: could MRI be an alternative screening test?;Eldred-Evans;Nat Rev Urol,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial;European Urology;2024-08

2. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer;Annals of Internal Medicine;2024-07

3. Magnetic Resonance Imaging in Prostate Cancer Screening;JAMA Oncology;2024-06-01

4. Key learning on the promise and limitations of MRI in prostate cancer screening;European Radiology;2024-02-05

5. The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review;BJUI Compass;2024-01-31